At Penn, NIH funding has supported work on CAR T-cell therapy, mRNA technology, rare disease treatments, and cancer therapies.
At Penn, NIH funding has supported work on CAR T-cell therapy, mRNA technology, rare disease treatments, and cancer therapies.